WJ-39
WJ-39 is an orally bioavailable aldose reductase inhibitor that activates Nrf2 signaling and suppresses NLRP3 inflammasome-driven oxidative stress and inflammation. It has demonstrated efficacy in ameliorating diabetic nephropathy, renal insufficiency, and fibrosis in preclinical in vivo studies.
Product Specifications
CAS Number
3009908-95-3
Product Name Alternative
Aldose reductase, WJ 39, WJ39
Field of Research
Cell Biology, Metabolism Research
Purity
99.45% (May vary between batches)
Solubility
DMSO:100 mg/mL (232.39 mM)
Smiles
O=C (CN1C=C (CC2=C (Cl) C (Cl) =CC=C2) C (C3=CC (OC) =CC=C31) =O) [O-].[K+]
Molecular Formula
C19H14Cl2KNO4
Molecular Weight
430.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MKD79152-01 50 mg
4-Amino-4H,5H,6H,7H-pyrazolo[1,5-a]pyridine-2-carboxylic acid hydrochloride
Sign In for Pricing
View Details